Login / Signup
Bingxin Cao
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Low Density Lipoprotein
Cardiovascular Disease
Randomized Controlled Trial
Vascular Endothelial Growth Factor
Top Venues
Oxidative medicine and cellular longevity
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Xiaopeng Guo
,
Yishan Guo
,
Zhiwen Wang
,
Bingxin Cao
,
Chuangsheng Zheng
,
Zhuanglin Zeng
,
Yumiao Wei
Reducing the Damage of Ox-LDL/LOX-1 Pathway to Vascular Endothelial Barrier Can Inhibit Atherosclerosis.
Oxidative medicine and cellular longevity
2022 (2022)